245 related articles for article (PubMed ID: 30945144)
21. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
Trivellin G; Butz H; Delhove J; Igreja S; Chahal HS; Zivkovic V; McKay T; Patócs A; Grossman AB; Korbonits M
Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E708-19. PubMed ID: 22811466
[TBL] [Abstract][Full Text] [Related]
23. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
25. Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors.
Müssnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Wierinckx A; Trouillas J; Fusco A; D'Angelo D
Cell Cycle; 2015; 14(16):2590-7. PubMed ID: 26125663
[TBL] [Abstract][Full Text] [Related]
26. Upregulated microRNAs in membranous glomerulonephropathy are associated with significant downregulation of IL6 and MYC mRNAs.
Barbagallo C; Passanisi R; Mirabella F; Cirnigliaro M; Costanzo A; Lauretta G; Barbagallo D; Bianchi C; Pagni F; Castorina S; Granata A; Di Pietro C; Ragusa M; Malatino LS; Purrello M
J Cell Physiol; 2019 Aug; 234(8):12625-12636. PubMed ID: 30515781
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of miR-216a-5p and miR-652-3p is associated with growth and invasion by targeting JAK2 and PRRX1 in GH-producing pituitary tumours.
Lee YJ; Kang CW; Oh JH; Kim J; Park JP; Moon JH; Kim EH; Lee S; Kim SH; Ku CR; Lee EJ
J Mol Endocrinol; 2021 Nov; 68(1):51-62. PubMed ID: 34738916
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
[TBL] [Abstract][Full Text] [Related]
30. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA Expression Profiling in Adrenal Myelolipoma.
Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P
J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas.
Zhao P; Cheng J; Li B; Nie D; Li C; Gui S; Wang H; Zhang Y
Cell Biol Toxicol; 2021 Aug; 37(4):633-651. PubMed ID: 33400021
[TBL] [Abstract][Full Text] [Related]
33. CBX1 is a direct target of miR-205-5p and contributes to the progression of pituitary tumor.
Hu A; Zhang Y; Zhao X; Li J; Ying Y
Pharmazie; 2019 Mar; 74(3):154-156. PubMed ID: 30961681
[TBL] [Abstract][Full Text] [Related]
34. miRNA profiles of canine cutaneous mast cell tumours with early nodal metastasis and evaluation as potential biomarkers.
Zamarian V; Ferrari R; Stefanello D; Ceciliani F; Grieco V; Minozzi G; Chiti LE; Arigoni M; Calogero R; Lecchi C
Sci Rep; 2020 Nov; 10(1):18918. PubMed ID: 33144602
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas.
Butz H; Likó I; Czirják S; Igaz P; Khan MM; Zivkovic V; Bálint K; Korbonits M; Rácz K; Patócs A
J Clin Endocrinol Metab; 2010 Oct; 95(10):E181-91. PubMed ID: 20668041
[TBL] [Abstract][Full Text] [Related]
36. Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
Müller S; Nowak K
Biomed Res Int; 2014; 2014():948408. PubMed ID: 24977165
[TBL] [Abstract][Full Text] [Related]
37. 3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course Treatment.
Kunigenas L; Stankevicius V; Dulskas A; Budginaite E; Alzbutas G; Stratilatovas E; Cordes N; Suziedelis K
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32316138
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
39. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
Wei Z; Zhou C; Liu M; Yao Y; Sun J; Xiao J; Ma W; Zhu H; Wang R
Pituitary; 2015 Oct; 18(5):710-21. PubMed ID: 25862551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
